Table 3.

Risk for developing second primary infection-related solid tumors among reported HIV/AIDS+ adult DLBCL survivors, SEER, 2000 to 2014

Second primary malignancy siteHIV/AIDSNo known HIV/AIDS*
ObsSIR95% CIObsSIR95% CI
Oropharynx/tonsil<51.250.03-6.94211.030.64-1.58
Stomach00NA621.541.18-1.98
Anus1468.3437.36-115172.091.22-3.34
Liver<52.450.51-7.16731.831.43-2.30
Cervix uteri<57.840.20-43.6980.800.35-1.58
  • NA, not applicable.

  • * Includes HIV/AIDS status NA, reflecting individual SEER registry practices.

  • Indicates 95% CI excludes 1.00, corresponding to 2-sided P < .05.